Global Times: Xi returns to Beijing after state visits to three SE.Asian countries

Global Times: Xi returns to Beijing after state visits to three SE.Asian countries

BEIJING, April 20, 2025 /PRNewswire/ -- Chinese President Xi Jinping returned to Beijing on Friday afternoon after wrapping up state visits to Vietnam, Malaysia and Cambodia, the Xinhua News Agency reported on Friday. During Xi's first state visits...

Global Times: China, Cambodia set cooperation model for nations of different sizes, Xi says

Global Times: China, Cambodia set cooperation model for nations of different sizes, Xi says

BEIJING, April 18, 2025 /PRNewswire/ -- Chinese President Xi Jinping on Thursday held talks with Cambodian Prime Minister Hun Manet. The two leaders agreed to build an all-weather community with shared future in a new era and designated 2025...

Global Times: China remains an 'ideal, secure and promising' destination for foreign investors: Xi

Global Times: China remains an 'ideal, secure and promising' destination for foreign investors: Xi

BEIJING, April 1, 2025 /PRNewswire/ -- As China wraps up a week in which it hosted two top-level international forums - the China Development Forum (CDF) 2025 and the Boao Forum for Asia (BFA) Annual Meeting 2025 - to drive home its commitment to...

ICAC Chief visits Middle East to foster anti-graft collaborations

ICAC Chief visits Middle East to foster anti-graft collaborations

RIYADH, Saudi Arabia and ABU DHABI, UAE and HONG KONG, Feb. 28, 2025 /PRNewswire/ -- ICAC Commissioner Woo Ying-ming has led a delegation to visit Saudi Arabia and the United Arab Emirates (UAE) early this week to foster closer ties in...

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI, Feb. 23, 2025 /PRNewswire/ -- BioCity Biopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist, SC0062, met the 12-week primary endpoint of a reduction in proteinuria in the diabetic kidney disease (DKD)...

ZICC: The Farm with Wings

ZICC: The Farm with Wings

BEIJING, Jan. 16, 2025 /PRNewswire/ -- In Ningbo, Zhejiang, David W. Ferguson, honorary chief English editor at Foreign Languages Press, met Jin Lishen, the local Fruit and Vegetable King, and included Jin's story in his new book China's Development...

Global Times: Xi stresses adherence to 'one country, two systems' as Macao celebrates 25th anniversary of return to motherland

Global Times: Xi stresses adherence to 'one country, two systems' as Macao celebrates 25th anniversary of return to motherland

BEIJING, Dec. 21, 2024 /PRNewswire/ -- Chinese President Xi Jinping stressed on Friday the long-term adherence to "one country, two systems" as Macao celebrates a quarter-century of transformative success since its return to the motherland. At a...

menu
menu